Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 373-380

  Termsarasab, Ubonvan ^a   Cho, Hyun Jong ^b   Kim, Dong Hwan ^a   Chong, Saeho ^a   Chung, Suk Jae ^a   Shim, Chang Koo ^a   Moon, Hyun Tae ^a   Kim, Dae Duk ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Arachidic acid; Chitosan oligosaccharide; Doxorubicin; Head and neck cancer; Self assembly

Indexed keywords

ARACHIDIC ACID; CHITOSAN; DOXORUBICIN; NANOPARTICLE; OLIGOSACCHARIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MORPHOLOGY; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUBSTITUTION REACTION; SYNTHESIS; TUMOR XENOGRAFT; ZETA POTENTIAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CHITOSAN; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EICOSANOIC ACIDS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; OLIGOSACCHARIDES; PARTICLE SIZE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84872765812     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.11.018     Document Type: Article

References (26)

1. M. Airoldi, L. Cattel, P. Milla, F. Pedani, M. Garzaro, and F. Dosio Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: clinical and unexpected pharmacokinetic interactions Anticancer Res. 28 2008 2519 2527
2. H.M. Aliabadi, D.R. Brocks, and A. Lavasanifar Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution Biomaterials 26 2005 7251 7259
3. S.Y. Chae, S. Son, M. Lee, M.K. Jang, and J.W. Nah Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier J. Control. Release 109 2005 330 344
4. M.D. Chavanpatil, A. Khdair, and J. Panyam Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery J. Nanosci. Nanotechnol. 6 2006 2651 2663
5. H.J. Cho, S. Chong, S.J. Chung, C.K. Shim, and D.D. Kim Poly-l-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment Pharm. Res. 29 2012 1007 1019
6. ® for tumor-targeted delivery of docetaxel Biomaterials 32 2011 7181 7190
7. H.J. Cho, I.S. Yoon, H.Y. Yoon, H. Koo, Y.J. Jin, S.H. Ko, J.S. Shim, K. Kim, I.C. Kwon, and D.D. Kim Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin Biomaterials 33 2012 1190 1200
8. J.S. Choi, K. Seo, and J.W. Yoo Recent advances in PLGA particulate systems for drug delivery J. Pharm. Invest. 42 2012 155 163
9. S. Kaida, H. Cabral, M. Kumagai, A. Kishimura, Y. Terada, M. Sekino, I. Aoki, N. Nishiyama, T. Tani, and K. Kataoka Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model Cancer Res. 70 2010 7031 7041
10. N. Kolishetti, S. Dhar, P.M. Valencia, L.Q. Lin, R. Karnik, S.J. Lippard, R. Langer, and O.C. Farokhzad Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy Proc. Natl. Acad. Sci. U. S. A. 1793 2010 17939 17944
11. F. Kratz, G. Ehling, H. Kauffmann, and C. Unger Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl) hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin Hum. Exp. Toxicol. 26 2007 19 35
12. M. Kumar, R.A.A. Muzzarelli, C. Muzzarelli, H. Sashiwa, and A. Domb Chitosan chemistry and pharmaceutical perspectives Chem. Rev. 1014 2004 6017 6084
13. G.S. Kwon Polymeric micelles for delivery of poorly water-soluble compounds Crit. Rev. Ther. Drug Carrier Syst. 20 2003 357 403
14. J.Y. Lee, Y.S. Choi, J.S. Suh, Y.M. Kwon, V.C. Yang, S.J. Lee, C.P. Chung, and Y.J. Park Cell penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy Int. J. Cancer 128 2011 2470 2480
15. K. Lee, I. Kwon, Y.H. Kim, W. Jo, and S. Jeong Preparation of chitosan self-aggregates as a gene delivery system J. Control. Release 51 1998 213 220
16. L. Li, and Y.B. Tan Preparation and properties of mixed micelles made of Pluronic polymer and PEG-PE J. Colloid Interface Sci. 317 2008 326 331
17. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
18. R. Muzzarelli, and C. Muzzarelli Chitosan chemistry: relevance to the biomedical sciences Adv. Polym. Sci. 186 2005 151 209
19. J.H. Park, S. Kwon, J.O. Nam, R.W. Park, H. Chung, S.B. Seo, I.S. Kim, I.C. Kwon, and S.Y. Jeong Self-assembled nanoparticles based on glycol chitosan bearing 5 beta-cholanic acid for RGD peptide delivery J. Control. Release 95 2004 579 588
20. C.W. Reuter, M.A. Morgan, and A. Eckardt Targeting EGF-receptor- signalling in squamous cell carcinomas of the head and neck Br. J. Cancer 96 2007 408 416
21. A.B. Vishu Kumar, M.C. Varadaraj, R.G. Lalitha, and R.N. Tharanathan Low molecular weight chitosans: preparation with the aid of papain and characterization Biochim. Biophys. Acta 1670 2004 137 146
22. H. Wildiers, R. Jurcut, J. Ganame, L. Herbots, P. Neven, J. De Backer, H. Denys, V. Cocquyt, F. Rademakers, and J.U. Voigt A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients Crit. Rev. Oncol. Hematol. 67 2008 133 138
23. H.Y. Yoon, H. Koo, K.Y. Choi, S.J. Lee, K. Kim, I.C. Kwon, J.F. Leary, K. Park, S.H. Yuk, J.H. Park, and K. Choi Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy Biomaterials 33 2012 3980 3989
24. J. You, F.Q. Hu, Y.Z. Du, H. Yuan, and B.F. Ye High cytotoxicity and resistant-cell reversal of novel paclitaxel loaded micelles by enhancing the molecular-target delivery of the drug Nanotechnology 18 2007 495101
25. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D.A. Berk, V.P. Torchilin, and R.K. Jain Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 55 1995 3752 3756
26. W. Zauner, M. Ogris, and E. Wagner Polylysine-based transfection systems utilizing receptor-mediated delivery Adv. Drug Deliv. Rev. 30 1998 97 113